Screener
Agios Pharmaceuticals AGIO Income Taxes Payable
Income Taxes Payable at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Prepaid expenses and other current and non-current assets | (7,344) | (3,746) |
| Accounts payable | (1,913) | 1,084 |
| Accrued expenses and other current liabilities | (10,812) | (11,572) |
| Income taxes payable | — | (871) |
| Operating lease liabilities | (9,036) | (8,228) |
| Other non-current liabilities | 150 | (779) |
| Net cash used in operating activities | (176,232) | (188,613) |
| Investing activities |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's income taxes payable?
- Agios Pharmaceuticals (AGIO) reported income taxes payable of $0 in Q2 2026.
- What does income taxes payable mean?
- Current income taxes owed to federal, state, and local tax authorities for the current and prior periods.
Ask your AI about Agios Pharmaceuticals's income taxes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude